Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...

Related Keywords

Boston ,Massachusetts ,United States ,Watertown ,Russia ,Ukraine ,American ,Appointedjim Tobin ,Kathryn Morris ,Maria Palasis ,Harlanw Waksal ,Boston Scientific Corporation ,Company Board Of Directors ,Baxter International ,Biogen Inc ,Meeting Of The American Rhinologic Society ,Nasdaq ,Lyra Therapeutics Inc ,Board At Transmedics Inc ,Lyra Therapeutics ,Chief Executive Officer ,Combined Otolaryngology Spring Meetings ,Fourth Quarter ,Clinical Developments ,Receive Top Clinical Award ,Annual Meeting ,American Rhinologic Society ,Science Maurice Cottle Award ,Month Post Treatment Data ,Executive Chairman ,Kadmon Holdings ,Jim Tobin ,Chief Operating Officer ,Board Member ,Globus Medical ,Impulse Dynamics ,Additional Milestones Anticipated ,Private Securities Litigation Reform Act ,Annual Report ,Nc ,